Reuters logo
BRIEF-Avita says co initiated legal process to cancel Renovacare patent
May 11, 2017 / 12:25 AM / 6 months ago

BRIEF-Avita says co initiated legal process to cancel Renovacare patent

May 11 (Reuters) - Avita Medical Ltd:

* Avita initiates legal process to cancel Renovacare patent

* Filed an Inter Partes Review (IPR) petition against U.S. patent owned by Renovacare Sciences Corp

* “Avita holds that all claims in the ‘430 patent are unpatentable and should be cancelled” Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below